[November 27, 2015] |
|
Research and Markets: Global Ovarian Cancer Pipeline Review 2015
Research and Markets (http://www.researchandmarkets.com/research/xr94gq/ovarian_cancer)
has announced the addition of the "Ovarian
Cancer - Pipeline Review, 2015" report to their offering.
The report provides comprehensive information on the pipeline products
with comparative analysis of the products at various stages of
development. The report reviews major players involved in the pipeline
product development. It also provides information about clinical trials
in progress, which includes trial phase, trial status, trial start and
end dates, and, the number of trials for the key Ovarian Cancer
diagnostic tests pipeline products.
Scope
-
Extensive coverage of the Ovarian Cancer diagnostic tests under
development
-
The report reviews details of major pipeline products which includes,
product description, licensing and collaboration details and other
developmental activities
-
The report reviews the major players involved in the development of
Ovarian Cncer diagnostic tests and list all their pipeline projects
-
The coverage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued stage
-
The report provides key clinical trial data of ongoing trials specific
to pipeline products
-
Recent developments in the segment / industry
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Products under Development
4 Ovarian Cancer - Pipeline Products under Development by Companies
5 Ovarian Cancer Companies and Product Overview
6 Ovarian Cancer- Recent Developments
7 Appendix
Companies Mentioned
-
A&G Pharmaceutical, Inc.
-
Abcodia Ltd.
-
Abnova Corporation
-
Adaptive Biotechnologies Corporation
-
Almac Diagnostics Limited
-
AroCell AB
-
Institut National de la Sante et de la Recherche Medicale
-
InterGenetics Incorporated
-
IV Diagnostics, Inc.
-
KIYATEC Inc.
-
Lab Discoveries Ltd.
-
Novel Bio-spectrum Technologies, Inc.
-
NuCana BioMed Limited
-
Oncgnostics GmbH
-
Orion Genomics LLC
-
Oryzon Genomics S.A.
-
OTraces Inc.
-
OvaGene Oncology Inc.
-
PeriRx LLC
-
Pronota NV
-
Protagen AG
-
Proteomika
-
Provista Diagnostics Inc.
-
RiboMed Biotechnologies, Inc.
-
Rice University
-
US Biomarkers, Inc.
-
Vermillion, Inc.
-
Vitatex Inc.
-
Vitruvian Biomedical, Inc.
-
Yale University
For more information visit http://www.researchandmarkets.com/research/xr94gq/ovarian_cancer
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005267/en/
[ Back To TMCnet.com's Homepage ]
|